Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
61.376,21
0,95%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Zosano Pharma Corporation (ZSAN) Zosano Pharma Corporation (ZSAN) Notizie

ZSAN

Zosano Pharma (ZSAN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ZSAN
DataOraFonteTitoloSimboloCompagnia
19/07/202217:48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ZSANZosano Pharma Corporation
08/06/202201:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZSANZosano Pharma Corporation
02/06/202214:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
02/06/202214:00GlobeNewswire Inc.Zosano Pharma Files Voluntary Petition for Relief Under Chapter 11NASDAQ:ZSANZosano Pharma Corporation
13/05/202222:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ZSANZosano Pharma Corporation
13/05/202222:00GlobeNewswire Inc.Zosano Pharma Reports First Quarter 2022 Financial ResultsNASDAQ:ZSANZosano Pharma Corporation
29/04/202222:02Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ZSANZosano Pharma Corporation
29/04/202222:00GlobeNewswire Inc.Zosano Pharma Provides Corporate UpdateNASDAQ:ZSANZosano Pharma Corporation
11/04/202214:00GlobeNewswire Inc.Zosano Pharma Announces Reverse Stock Split Effective TodayNASDAQ:ZSANZosano Pharma Corporation
01/04/202222:22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ZSANZosano Pharma Corporation
22/03/202212:46TipRanksMaxim Group Thinks Zosano Pharma’s Stock is Going to RecoverNASDAQ:ZSANZosano Pharma Corporation
17/03/202221:05GlobeNewswire Inc.Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial ResultsNASDAQ:ZSANZosano Pharma Corporation
14/02/202212:19Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ZSANZosano Pharma Corporation
11/02/202223:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ZSANZosano Pharma Corporation
09/02/202223:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ZSANZosano Pharma Corporation
09/02/202203:55GlobeNewswire Inc.Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and WarrantsNASDAQ:ZSANZosano Pharma Corporation
08/02/202222:10GlobeNewswire Inc.Zosano Pharma Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:ZSANZosano Pharma Corporation
05/01/202218:01GlobeNewswire Inc.CORRECTION - Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher DoseNASDAQ:ZSANZosano Pharma Corporation
05/01/202215:20GlobeNewswire Inc.Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher DoseNASDAQ:ZSANZosano Pharma Corporation
13/12/202122:30GlobeNewswire Inc.Zosano Pharma Announces Changes to Board of Directors; Appoints Cross Functional Business Executive Elaine M. YangNASDAQ:ZSANZosano Pharma Corporation
30/11/202103:45GlobeNewswire Inc.Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZSANZosano Pharma Corporation
17/11/202114:00GlobeNewswire Inc.Zosano Pharma Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch SystemNASDAQ:ZSANZosano Pharma Corporation
10/11/202122:10GlobeNewswire Inc.Zosano Pharma Reports Third Quarter 2021 Financial ResultsNASDAQ:ZSANZosano Pharma Corporation
04/10/202114:00GlobeNewswire Inc.Zosano Pharma Granted Type C Meeting with FDA Regarding NDA Resubmission for M207 Following Preliminary Top-Line Pharmacokinetic Study ResultsNASDAQ:ZSANZosano Pharma Corporation
02/09/202122:30GlobeNewswire Inc.Zosano Pharma to Present at the H.C. Wainwright Virtual Global Investment ConferenceNASDAQ:ZSANZosano Pharma Corporation
10/08/202122:05GlobeNewswire Inc.Zosano Pharma Reports Second Quarter 2021 Financial ResultsNASDAQ:ZSANZosano Pharma Corporation
20/07/202114:30GlobeNewswire Inc.Zosano Pharma Announces Issuance of U.S. Patent for Method of Rapidly Achieving Therapeutic Levels with M207 for the Acute Tr...NASDAQ:ZSANZosano Pharma Corporation
15/07/202112:30Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ZSANZosano Pharma Corporation
02/07/202123:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ZSANZosano Pharma Corporation
21/06/202122:09Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ZSANZosano Pharma Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ZSAN

La tua Cronologia

BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
BFF
BFF Bank
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
IVG
Iveco Group NV
BIT
RACE
Ferrari NV
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
NEXI
Nexi S.p.A
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
MB
Mediobanca Banca di Cred...
BIT
PRY
Prysmian
BIT
STMMI
ST Microelectronics
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network